Patent · US Active

Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof

US8877714B2 · kind B2 · utility

10Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 14, 2006
Grant dateNov 4, 2014
Priority date
Expiry dateAug 15, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to receptor-selective variants of the low-density lipoprotein receptor-associated protein (RAP) and compositions thereof, methods of generating such variants and methods of using such receptor-selective RAP variant compositions for therapeutic purposes. The invention also relates to antibodies that bind to one or a small subset of CR-containing proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.